Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lumenlabs Far-UVC Disinfection System Protected Tokyo Olympic Athletes from Ongoing Coronavirus Threat

Patent pending Lumenizer™ filtered Far-UVC technology provided safe and effective continuous disinfection for athletic facilities.


News provided by

Lumenlabs, LLC

Aug 17, 2021, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Lumenlabs™️
Lumenlabs™️
Youtube
Youtube

SAN DIEGO, Aug. 17, 2021 /PRNewswire-PRWeb/ -- The historic Tokyo Olympics began with strict constraints to prevent the spread of highly infectious coronavirus variants. To protect the health of their athletes from the threat of airborne pathogens, the Chinese national team relied on patent pending Lumenizer filtered Far-UVC light technology, announced Scott Gant, Lumenlabs, LLC President and Co-Founder.

"Lumenizer germicidal fixtures are protected by patent pending technology and trade secrets that are revolutionary breakthroughs in the human-safe application of Far-UVC light," Gant stated. "The Covid-19 pandemic and emerging variant viruses has created a growing $34 billion dollar market for proactive disinfection. The Lumenizer disinfection system represents a safe and effective 222nm Far-UVC application for occupied areas. Our Lumenlabs team brings this lifesaving and revolutionary technology to market through a network of global dealers and strategic partnerships."

Lumenizer germicidal fixtures are protected by patent pending technology and trade secrets that are revolutionary breakthroughs in the human-safe application of Far-UVC light, Gant stated.

Post this

Postponed a year due to the Covid-19 pandemic, in 2021 Tokyo Olympics officials established a wide range of public health measures from vaccines to quarantines and masking to sanitation and attendance restrictions. In addition to having all of their Olympic athletes and staff vaccinated, to provide a comprehensive layer of protection, the Chinese national team installed advanced Lumenlabs Lumenizer far ultraviolet disinfection light fixtures throughout their housing and training facilities.

Developed by Lumenlabs, LLC, a global company with R&D centers in the United States and China, Lumenizer filtered Far-UVC 222nm light technology provides effective, automated and continuous disinfection of occupied spaces. Human-safe Lumenizer disinfection is proven to be 99.9% effective at deactivating airborne viruses and bacteria, achieved as the pathogens lose activity and cannot regenerate.

In 2013, the Radiology Research Center at the Columbia University School of Public Health discovered that extreme ultraviolet light can be used to eliminate airborne microorganisms such as viruses and bacteria. Experiments were conducted to prove the efficacy and safety. In 2018, Dr. David Brenner published a paper in the authoritative scientific journal "Nature" confirming that 222nm far ultraviolet light rays do not harm the skin and eyes.

For decades conventional germicidal UV light, emitting around 254nm, has been used to disinfect critical unoccupied spaces such as hospital surgery theaters. UV light is well-established as a highly efficient anti-microbial against bacteria and viruses, however, it cannot be used when people are present because higher wavelengths penetrate more deeply into tissues potentially causing damage to the skin and eyes. Far-UVC emits lower wavelengths than traditional UVC with a peak at 222nm that does not penetrate the human dead skin layer or the eye tear layer.

Compact and easy to install, the Lumenizer model 300 germicidal fixture features 60W input power, an efficient and powerful Far-UVC output with a patent pending tilting bulb ceiling or wall mount that uniformly disinfects air and surfaces of 172 ft² area (16 meters²). Three ultra-high purity quartz glass bulbs with a patent pending Lumenlabs light source design optimize the efficacy of Far-UVC generation. A built-in 100-layer nano coated filter provides the highest Far-UVC pass rate and the blockage of harmful UV. Other features include an innovative high-voltage high-frequency driver, compact design, automated instant start, replaceable bulb, cost efficiency, longevity and safety, and is ozone neutral and mercury free.

For more information on Lumenlabs, LLC and Lumenizer disinfection system applications for your business and community, visit Lumenlabs.com.

About Lumenlabs, LLC

Dedicated to creating a healthier future, Lumenlabs, LLC is a global company with a synergistic wealth of advanced technological, manufacturing, supply chain management and marketing expertise. The Lumenizer™ disinfection system is protected by patent pending technology and trade secrets that represent major breakthroughs in the human-safe application of Far-UVC light. The Lumenlabs team is driven to create innovative filtered Far-UVC solutions that provide safe and effective continuous sanitation for the spaces where people work, study, live or play. For more information, visit lumenlabs.com or email [email protected].

For safety and efficacy published papers go to Lumenlabs.com/resources.

Follow Lumenlabs, LLC on Facebook, Instagram, Twitter, LinkedIn, and YouTube.

Media Contact

Lumenlabs Support, Lumenlabs, LLC, +1 888-586-3688 Ext: 0, [email protected]

SOURCE Lumenlabs, LLC

Related Links

http://lumenlabs.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.